Our CEO, Dr Peter A Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how we change the model informed drug development landscape of the pharmaceutical industry with our cutting-edge tools and methods, from early clinical trials to drug approval. Read the full interview here.